Trial Profile
Detection of non-muscle invasive bladder cancer using PVP-Hypericin (Vidon) fluorescence cystoscopy (Hypericin PDD)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Hypericin sodium (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- Sponsors Sanochemia Pharmazeutika
- 30 Jul 2015 New trial record